Increase of GAP-43 in the rat cerebellum following unilateral striatal 6-OHDA lesion

Synapse

Volumn 56, Issue 3, 2005, Pages 170-174

  Perović, Milka ^a   Mladenović, Aleksandra ^a   Rakić, Ljubisav ^b   Ruždijić, Sabera ^a   Kanazir, Selma ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b SERBIAN ACADEMY OF SCIENCES AND ARTS   (Serbia)

Author keywords

Cerebellum; GAP 43; Neural plasticity; Parkinson's disease; Synaptophysin

Indexed keywords

BIOLOGICAL MARKER; BRAIN PROTEIN; NEUROMODULIN; OXIDOPAMINE; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN LEVEL; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; EXPERIMENTAL MODEL; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL PLASTICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORIMOTOR CORTEX; SYNAPSE; TISSUE STRUCTURE; WESTERN BLOTTING;

ANIMALS; CEREBELLUM; CORPUS STRIATUM; GAP-43 PROTEIN; MALE; OXIDOPAMINE; RATS;

EID: 17044440352     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20142     Document Type: Article

References (34)

1. Anglade P, Tsuji S, Javoy-Agid F, Agid Y, Hirsch EC. 1995. Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease. Ann Neurol 37:265-272.
2. Anglade P, Mouatt-Prigent A, Agid Y, Hirsch E. 1996. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration 5:121-128.
3. Bendotti C, Servadio A, Samanin R. 1991. Distribution of GAP43 mRNA in the brain stem of adult rats as evidenced by in situ hybridization: localization within monoaminergic neurons. J Neurosci 11:600-607.
4. Benowitz LI, Routtenberg A. 1997. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20:84-91.
5. Bergmann M, Post A, Rittel I, Bechmann I, Nitsch R. 1997. Expression of synaptophysin in sprouting neurons after entorhinal lesion in the rat. Exp Brain Res 117:80-86.
6. Calabresi P, Centonze D, Bernardi G. 2000. Electrophysiology of dopamine in normal and denervated striatal neurons. Trends Neurosci 23:857-63.
7. Carlson JD, Pearlstein RD, Buchholz J, Iacono RP, Maeda G. 1999. Regional metabolic changes in the pedunculopontine nucleus of unilateral 6-hydroxydopamine Parkinson's model rats. Brain Res 828:12-19.
8. Fukuda M, Mentis MJ, Ma Y, Dhawan V, Antonini A, Lang AE, Lozano AM, Hammerstad J, Lyons K, Koller WC, Moeller JR, Eidelberg D. 2001. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain 124:1601-1609.
9. Harrison PJ, Eastwood SL. 2001. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11:508-519.
10. Hurley MJ, Mash DC, Jenner P. 2003. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. Eur J Neurosci 18:2668-2672.
11. Ingham CA, Hood SH, Arbuthnott GW. 1991. A light and electron microscopical study of enkephalin-immunoreactive structures in the rat neostriatum after removal of the nigrostriatal dopaminergic pathway. Neuroscience 42:715-730.
12. Ingham CA, Hood SH, Taggart P, Arbuthnott GW. 1998. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 18:4732-4743.
13. Iwata SI, Nomoto M, Fukuda T. 1999. Quantification of neuromodulin (GAP-43, B-50) and synapsin I in rat striata. Nihon Shinkei Seishin Yakurigaku Zasshi 19:261-266.
14. Iwata SI, Nomoto M, Fukuda T. 2001. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine. Synapse 39:16-22.
15. Kirk D, Rosenblad C, Bjorklund A. 1998. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152:259-277.
16. Kizer JS, Palkovits M, Brownstein MJ. 1976. The projections of the A8, A9 and A10 dopaminergic cell bodies: evidence for a nigral-hypothalamic-median eminence dopaminergic pathway. Brain Res 108:363-370.
17. Koike Y, Takahashi A. 1997. Autonomic dysfunction in Parkinson's disease. Eur Neurol 38,82:8-12.
18. Masliah E, Terry RD, Alford M, DeTeresa R. 1990. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem 38:837-844.
19. Mladenovic A, Perovic M, Raicevic N, Kanazir S, Rakic L, Ruzdijic S. 2004. 6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats. Brain Res 996:237-245.
20. Oestreicher AB, Gispen WH. 1986. Comparison of the immunocytochemical distribution of the phosphoprotein B-50 in the cerebellum and hippocampus of immature and adult rat brain. Brain Res 375:267-279.
21. Orieux G, Francois C, Feger J, Hirsch EC. 2002. Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat. J Neurosci 22:8762-8770.
22. Panagopoulos NT, Papadopoulos GC, Matsokis NA. 1991. Dopaminergic innervation and binding in the rat cerebellum. Neurosci Lett 130:208-212.
23. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. New York: Academic Press.
24. Piao YS, Mori F, Hayashi S, Tanji K, Yoshimoto M, Kakita A, Wakabayashi K, Takahashi H. 2003. Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies. Acta Neuropathol 105:403-409.
25. Pinto S, Thobois S, Costes N, Le Bars D, Benabid AL, Broussolle E, Pollak P, Gentil M. 2004. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study. Brain 127:602-615.
26. Sauer H, Oertel WH. 1994. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59:401-415.
27. Schwarting RK, Huston JP. 1997. Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions. Neurotoxicology 18:689-708.
28. Skene H. 1989. Axonal growth-associated proteins. Annu Rev Neurosci 12:127-156.
29. Sudhof TC. 1995. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 375:645-653.
30. Timmermann L, Gross J, Dirks M, Volkmann J, Freund HJ, Schnitzler A. 2003. The cerebral oscillatory network of parkinsonian resting tremor. Brain 126:199-212.
31. Tolwani RJ, Jakowec MW, Petzinger GM, Green S, Waggie K. 1999. Experimental models of Parkinson's disease: insights from many models. Lab Anim Sci 49:363-371.
32. Torack RM, Miller JW. 1994. Immunoreactive changes resulting from dopaminergic denervation of the dentate gyrus of the rat hippocampal formation. Neurosci Lett 169:9-12.
33. Woolhead CL, Zhang Y, Lieberman AR, Schachner M, Emson PC, Anderson PN. 1998. Differential effects of autologous peripheral nerve grafts to the corpus striatum of adult rats on the regeneration of axons of striatal and nigral neurons and on the expression of GAP-43 and the cell adhesion molecules N-CAM and L1. J Comp Neurol 391:259-273.
34. Zhou FC, Bledsoe S, Murphy J. 1991. Serotoninergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain. Brain Res 556:108-116.